JAMES C BLAIR Insider Trading $CLVS Clovis Oncology, Inc.
Get free email notifications about insider trading for JAMES C BLAIR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES C BLAIR. JAMES C BLAIR is 10% Owner in SENOMYX INC ($SNMX) and 10% Owner in INTRALASE CORP ($ILSE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in PHARMION CORP ($PHRM) and 10% Owner in SANTARUS INC ($SNTS) and Director in NUVASIVE INC ($NUVA) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and 10% Owner in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and Director in CADENCE PHARMACEUTICALS INC ($CADX) and 10% Owner in SENORX INC ($SENO) and Director in aTYR PHARMA INC ($LIFE) and 10% Owner in Pernix Sleep, Inc. ($SOMX) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and Director in Volcano Corp ($VOLC) and Director in ZOGENIX, INC. ($ZGNX) and 10% Owner in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in TANDEM DIABETES CARE INC ($TNDM) and Director in Clovis Oncology, Inc. ($CLVS) and 10% Owner in REVA Medical, Inc. ($RVA) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).
JAMES C BLAIR in Clovis Oncology, Inc.
Trading Symbol: CLVSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES C BLAIR: Director
Holdings: 33,439 shares
Current Value: $2,006,340
Latest Transaction: Jun 05 2020
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES C BLAIR in Clovis Oncology, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ACHN, ALIM, LIFE, CADX, CLVS, DRNA, DRTX, ESPR, EVOK, IOMI, ILSE, NSTR, NUVA, TZYM, OREX, PRTK, SOMX, PHRM, RVA, SNTS, SNMX, SENO, TNDM, TBRA, VNDA, VCYT, VOLC, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2020 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Jun 05 2020 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.97 | 20,000 | 119,400 | 20,000 | 0 to 20 K |
Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.70 | 20,000 | 114,000 | 33,439 | 13.4 K to 33.4 K (+148.82 %) |
Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.97 | 20,000 | 119,400 | 20,000 | 0 to 20 K |
Aug 20 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 5.70 | 20,000 | 114,000 | 33,439 | 13.4 K to 33.4 K (+148.82 %) |
Jun 10 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
Mar 18 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 522 | 0 | 13,439 | 12.9 K to 13.4 K (+4.04 %) |
Mar 18 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 701 | 0 | 10,105 | 9.4 K to 10.1 K (+7.45 %) |
Mar 18 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Mar 18 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | S | 27.79 | 17,056 | 473,986 | 0 | 17.1 K to 0 (-100.00 %) |
Feb 05 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Feb 05 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 1,000,000 | 0 | 0 | 1000 K to 0 (-100.00 %) |
Feb 05 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Feb 05 2019 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 1,000,000 | 0 | 0 | 1000 K to 0 (-100.00 %) |
Oct 15 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
May 23 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 5,897 | 0 | 12,917 | 7 K to 12.9 K (+84.00 %) |
May 23 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 32,760 | 0 | 0 | 32.8 K to 0 (-100.00 %) |
Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 6,477 | 0 | 9,404 | 2.9 K to 9.4 K (+221.28 %) |
Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 4,835 | 0 | 7,020 | 2.2 K to 7 K (+221.28 %) |
Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 92,518 | 0 | 0 | 92.5 K to 0 (-100.00 %) |
Aug 08 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | S | 78.61 | 18,450 | 1,450,355 | 17,056 | 35.5 K to 17.1 K (-51.96 %) |
Jun 27 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 2,869 | 0 | 92,518 | 89.6 K to 92.5 K (+3.20 %) |
Jun 27 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 286,857 | 0 | 1,000,000 | 1.3 M to 1000 K (-22.29 %) |
Jun 12 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 59.56 | 10,000 | 595,600 | 10,000 | |
Jun 13 2016 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 15.23 | 10,000 | 152,300 | 10,000 | |
Sep 24 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 794,888 | 0 | 1,286,857 | 2.1 M to 1.3 M (-38.18 %) |
Jul 17 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 2,185 | 0 | 2,185 | 0 to 2.2 K |
Jul 17 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 41,813 | 0 | 0 | 41.8 K to 0 (-100.00 %) |
Jun 15 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 87.15 | 10,000 | 871,500 | 10,000 | |
Mar 05 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | S | 77.70 | 8,528 | 662,626 | 35,506 | 44 K to 35.5 K (-19.37 %) |
Mar 05 2015 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 500,000 | 0 | 2,081,745 | 2.6 M to 2.1 M (-19.37 %) |
Jun 19 2014 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 44.52 | 12,414 | 552,671 | 12,414 | |
Jun 14 2013 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 71.11 | 12,414 | 882,760 | 12,414 | |
Jun 18 2012 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 19.46 | 12,414 | 241,576 | 12,414 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Page: 1